Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LANSOPRAZOLE Cause Therapy non-responder? 118 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 118 reports of Therapy non-responder have been filed in association with LANSOPRAZOLE (Lansoprazole). This represents 0.2% of all adverse event reports for LANSOPRAZOLE.

118
Reports of Therapy non-responder with LANSOPRAZOLE
0.2%
of all LANSOPRAZOLE reports
38
Deaths
63
Hospitalizations

How Dangerous Is Therapy non-responder From LANSOPRAZOLE?

Of the 118 reports, 38 (32.2%) resulted in death, 63 (53.4%) required hospitalization, and 51 (43.2%) were considered life-threatening.

Is Therapy non-responder Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LANSOPRAZOLE. However, 118 reports have been filed with the FAERS database.

What Other Side Effects Does LANSOPRAZOLE Cause?

Chronic kidney disease (32,517) Acute kidney injury (16,359) Renal failure (12,509) End stage renal disease (9,734) Renal injury (9,383) Tubulointerstitial nephritis (3,860) Death (2,517) Gastrooesophageal reflux disease (2,482) Off label use (2,183) Nephrogenic anaemia (2,162)

What Other Drugs Cause Therapy non-responder?

ETANERCEPT (3,472) APREMILAST (3,360) METHOTREXATE (2,965) RITUXIMAB (2,731) ADALIMUMAB (2,595) PREDNISONE (2,563) TREPROSTINIL (2,289) INFLIXIMAB (2,122) TOCILIZUMAB (1,775) HYDROXYCHLOROQUINE (1,699)

Which LANSOPRAZOLE Alternatives Have Lower Therapy non-responder Risk?

LANSOPRAZOLE vs LANTHANUM LANSOPRAZOLE vs LANTUS LANSOPRAZOLE vs LANTUS SOLOSTAR LANSOPRAZOLE vs LAPATINIB LANSOPRAZOLE vs LAPATINIB DITOSYLATE

Related Pages

LANSOPRAZOLE Full Profile All Therapy non-responder Reports All Drugs Causing Therapy non-responder LANSOPRAZOLE Demographics